Upgrade to SI Premium - Free Trial

Novocure (NVCR)

17.03 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/30/26 *Est.)

Latest Headlines

NovoCure Ltd. (NVCR) PT Raised to $20 at Wedbush July 24, 2026 7:47 AM - StreetInsider NovoCure Ltd. (NVCR) PT Lowered to $32 at H.C. Wainwright July 24, 2026 7:31 AM - StreetInsider NovoCure Ltd. (NVCR) PT Raised to $20 at Wells Fargo July 24, 2026 6:29 AM - StreetInsider Form 144 NovoCure Ltd Filed by: Leupin Nicolas July 23, 2026 4:22 PM - SEC Filing Novocure (NVCR) Tops Q2 EPS by 20c; offers guidance July 23, 2026 7:02 AM - StreetInsider Form 8-K NovoCure Ltd For: Jul 23 July 23, 2026 7:00 AM - SEC Filing Novocure Reports Second Quarter 2026 Financial Results July 23, 2026 7:00 AM - BizWire Form 10-Q NovoCure Ltd For: Jun 30 July 23, 2026 7:00 AM - SEC Filing JPMorgan Resumes NovoCure Ltd. (NVCR) at Neutral July 13, 2026 3:15 AM - StreetInsider Form 4 NovoCure Ltd For: Jun 30 Filed by: Puri Michal Nath July 1, 2026 4:34 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 30 Filed by: Leonard Frank X July 1, 2026 4:32 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 30 Filed by: Ben Arye Barak July 1, 2026 4:31 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 30 Filed by: Danziger Asaf July 1, 2026 4:30 PM - SEC Filing Novocure to Report Second Quarter 2026 Financial Results July 1, 2026 7:00 AM - BizWire Form 8-K NovoCure Ltd For: Jun 30 June 30, 2026 7:01 AM - SEC Filing Novocure's Optune Pax wins CE Mark for pancreatic cancer June 30, 2026 7:00 AM - StreetInsider Novocure’s Optune Pax® Receives CE Mark for the Treatment of Locally Advanced Pancreatic Cancer June 30, 2026 7:00 AM - BizWire FreeCast surges premarket; Accenture, Novocure slide June 18, 2026 8:02 AM - StreetInsider Novocure's TRIDENT trial misses primary endpoint in glioblastoma June 18, 2026 7:00 AM - StreetInsider Form 8-K NovoCure Ltd For: Jun 18 June 18, 2026 7:00 AM - SEC Filing Novocure Announces Topline Data from the Phase 3 TRIDENT Trial Evaluating Earlier Use of Tumor Treating Fields Therapy in Newly Diagnosed Glioblastoma June 18, 2026 7:00 AM - BizWire Form 8-K NovoCure Ltd For: Jun 03 June 5, 2026 4:30 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 04 Filed by: Leonard Frank X June 5, 2026 4:28 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 03 Filed by: LEUNG GABRIEL June 5, 2026 4:28 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 03 Filed by: Stafford Kristin June 5, 2026 4:28 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 03 Filed by: Ocean Allyson J June 5, 2026 4:27 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 03 Filed by: Scannell Timothy J June 5, 2026 4:27 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 03 Filed by: HILLEMAN JERYL L June 5, 2026 4:27 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 03 Filed by: Hung David June 5, 2026 4:26 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 03 Filed by: Madden Martin J. June 5, 2026 4:26 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 03 Filed by: VERNON W ANTHONY June 5, 2026 4:26 PM - SEC Filing Form 144 NovoCure Ltd Filed by: Leonard Frank X June 4, 2026 5:41 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 02 Filed by: LEUNG GABRIEL June 3, 2026 4:54 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 02 Filed by: Stafford Kristin June 3, 2026 4:54 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 02 Filed by: Ocean Allyson J June 3, 2026 4:54 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 02 Filed by: Scannell Timothy J June 3, 2026 4:53 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 02 Filed by: HILLEMAN JERYL L June 3, 2026 4:53 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 02 Filed by: VERNON W ANTHONY June 3, 2026 4:53 PM - SEC Filing Form 4 NovoCure Ltd For: Jun 02 Filed by: Hung David June 3, 2026 4:53 PM - SEC Filing Form DEFA14A NovoCure Ltd May 21, 2026 4:00 PM - SEC Filing Form SCHEDULE 13G/A NovoCure Ltd Filed by: Soleus Capital Master Fund, L.P. May 8, 2026 5:02 PM - SEC Filing NovoCure Ltd. (NVCR) PT Raised to $17 at Wells Fargo May 4, 2026 6:51 AM - StreetInsider NovoCure Ltd. (NVCR) PT Raised to $20 at Evercore ISI April 30, 2026 12:22 PM - StreetInsider Novocure (NVCR) Misses Q1 EPS by 13c, provides guidance April 30, 2026 7:13 AM - StreetInsider Form 8-K NovoCure Ltd For: Apr 30 April 30, 2026 7:02 AM - SEC Filing Form 10-Q NovoCure Ltd For: Mar 31 April 30, 2026 7:01 AM - SEC Filing Novocure Reports First Quarter 2026 Financial Results April 30, 2026 7:00 AM - BizWire Full Article List